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ABSTRACT
Interleukin-1 B is believed to contribute to the
pathophysiology of rheumatoid arthritis by activating
collagenase gene expression. We have used a cell
culture model of rabbit synovial fibroblasts to examine
the molecular mechanisms of IL-1,8-mediated
collagenase gene expression. Stimulation of rabbit
synovial fibroblasts with 10 ng/ml recombinant human
IL-1B resulted in a 20-fold increase in collagenase
mRNA by 12 h. Transient transfection studies using
collagenase promoter - CAT constructs demonstrated
that proximal sequences responded poorly to IL-13,S
possibly due to insufficient activation of AP-1 by this
cytokine. More distal sequences were required for IL-1,B
responsiveness, with a 4700 bp construct showing
-5-fold induction above control. To examine post-
transcriptional mechanisms, transcript from a human
collagenase cDNA was constitutively produced by the
simian virus 40 early promoter. IL-1(3 stabilized the
constitutively expressed human transcript. Further-
more, mutation of the ATTTA motifs in the 3' untrans-
lated region of the human gene also stabilized the
transcript. Finally, the rabbit coliagenase 3' untrans-
lated region destabilized a constitutively transcribed
chloramphenicol acetyltransferase transcript. These
data Indicate that in addition to activating transcription,
IL-1 B increases coliagenase transcript stability by
reversing the destabilizing effects of sequences in the
3' untranslated region.
INTRODUCTION
The matrix metalloproteinases (MMPs) are a family of enzymes
which degrade components of the extracellular matrix, thereby
regulating connective tissue turnover (1). One member of this
family, interstitial collagenase (MMP-1, E.C. 3.4.24.7), is
responsible for degradation of collagens type I, II, andm within
the extracellular matrix and is essential for efficient restructuing
of this tissue (2,3). This enzyme is produced by a variety of cells
in the body such as fibroblasts (4,5), macrophages (6), endothelial
cells (7), keratinocytes (8) and chondrocytes (9) and plays a major
role in normal processes such as wound healing (10) and uterine
resorption (11). Collagenase is inappropriately expressed in
disease states such as tumor invasion (12) and rheumatoid arthritis
(13). Indeed, synovial fibroblasts from the joints of patients with
rheumatoid disease secrete high levels of collagenase (14) which
contributes to cartilage degradation, bone resorption and
ultimately joint destruction (15,16).
In cultured fibroblasts, collagenase can be induced by the
protein kinase C agonist phorbol myristate acetate (PMA) (4,17),
or more physiologically relevant stimuli such as urate crystals
(18), IL-1 (19,20), TNF-a (21) and EGF (22). Of these agents,
IL-1 is known to mediate cartilage degradation (23,24) and
overexpression of this cytokine is observed in patients with
chronic inflammation and connective tissue disease (22,23,25).
Although IL-1 induction of collagenase is a major pathway in
extracellular matrix degradation, relatively little is known of the
molecular mechanisms by which this cytokine activates the
collagenase gene.
In vitro, recombinant IL-i1, induces collagenase steady-state
mRNA levels in cultured human and rabbit synovial fibroblasts
(25-27), and this is due in part to increased transcription of the
collagenase gene (26). The transcriptional response may involve
the activator protein-I (AP-1) binding site (5,28,29), which is
necessary but not sufficient for mediating the PMA response in
primary fibroblasts (30). However, regulation of the collagenase
promoter by IL-I may be more complex. A 73 bp human
promoter construct containing the AP-1 site has been reported
to respond to IL-I stimulation, but when additional upstream
sequence is added, IL-I inducibility is dramatically reduced (31).
Furthermore, a mutant form of IL- I( synthesized in vitro induced
the genes for c-Fos and c-Jun, without increasing expression of
the coilagenase gene, suggesting that AP-I may not play a major
role in IL-1 induction (32). These studies suggest that IL-I does
not activate collagenase gene expression through the same
transcriptional mechanisms as PMA.
Recent data suggest that post-transcriptional processes also
contribute to collagenase gene expression. The half-life of
collagenase mRNA is modulated by PMA (33) and EGF (22).
In epithelial cells, collagenase mRNA is undetectable in
unstimulated cells, despite a transcriptonally active gene (34).
*To whom correspondence should be addressed
1994 Oxford University Press
Nucleic Acids Research, 1994, Vol. 22, No. 22 4819
One key to understanding the mechanisms of post-transcriptional
regulation of collagenase may lie in sequence homology to other
genes. The 3' untranslated region (UTR) of the collagenase gene
contains three repeats of the sequence ATTTA (28), which has
been shown by several laboratories to regulate the stability of
cytokine and proto-oncogene mRNAs (35,36). These ATTTA
elements are conserved in the human and rabbit collagenase genes
(5,28), suggesting that they may play a role in gene regulation.
In the present study, we used a model of rabbit synovial
fibroblasts (RF) to study the regulation of collagenase gene
expression by IL-1a. These cells resemble primary cultures of
rheumatoid synovial cells in their response to experimental stimuli
(4). Importantly, in addition to conservation of the ATTTA motif
in their 3' UTRs, the human and rabbit collagenase genes share
extensive homology in their promoter regions (28,29). We
demonstrate that IL-l induction of collagenase gene expression
involves a modest transcriptional increase, which is accompanied
by an increase in mRNA stability.
MATERIALS AND METHODS
Cell culture
Rabbit synovial fibroblasts were prepared as described previously
(18). Cells were grown to confluency, then washed three times
with HBSS to remove traces of serum, and placed in DMEM
containing 0.2% lactalbumin hydrolysate (DMEM-LH). Cells
were left unstimulated, or treated with 10-8 M PMA or 10
ng/ml recombinant IL-1,B (graciously provided by Immunex
Research and Development Corp., Seattle, WA). Cells were used
between the third and seventh passage.
Plasmids constructs
Plasmids containing between 1176 and 127 bp of the rabbit
collagenase promoter linked to the chloramphenicol acetyl
transferase gene (CAT) have been described previously (30).
Larger promoter constructs were generated from a 4700 bp
Hindm fragment of the collagenase promoter cloned into pUC 18.
A 2400 bp fragment was produced by Bgll digestion within the
4700 bp promoter, and a second 3900 bp construct was made
by PstI digestion. The sticky ends produced from these digestion
were filled in, Hindm linkers were added and the ends were
ligated. Subsequently, partial digestion with Hindm produced
the 2400 bp, 3900 bp and 4700 bp fragments of the rabbit
collagenase gene promoter that were suitable for subcloning into
the unique HindI site within the multiple cloning site of the
vector pSVO-CAT. pGemB-R contains a fragment consisting of
600 bp of the rabbit collagenase promoter and 251 bp of the CAT
coding sequence cloned into the multicloning site of pGem-3
(Promega, Madison, WI). H9 is a cDNA corresponding to the
terminal 530 bp of the rabbit collagenase gene cloned into
pBR322. This fragment codes for the terminal 23 amino acids
and contains the entire 3' UTR (18). The human glyceraldehyde
phosphate dehydrogenase (GAPDH, ATCC) cDNA was used as
a loading control for Northern analysis. The human collagenase
expression plasmid pSG5HuCol (see below) was constructed by
cloning the 1700 bp of the human collagenase cDNA into the
EcoRI site of pSG5 (37). The 1700 bp human collagenase
fragment was also cloned into pSG5 in the opposite orientation
for riboprobe synthesis.
The ATTTA elements within pSG5HuCol were mutated to
GCCCG by oligonucleotide-directed mutagenesis using the
Altered Sites Mutagenesis Kit (Promega, Madison, WI). To
construct the plasmid SV2CATH9, SV2CAT was digested with
HpaIlBamHI which removed the SV40 polyadenylation site. The
vector was blunted with T4 polymerase and re-ligated with Bgll
linkers (pSV2CATAPA). An EcoRI fragment of H9 was cloned
into pBsSK+ (Stratagene, La Jolla, CA) and then removed as
a Bgmll-BamHI fragment. This fragment was then cloned into
the Bgll site of pSV2CATAPA to give rise to SV2CATH9. The
rabbit sequence of SV2CATH9 contains a polyadenylation site
to replace that of SV2CAT.
Assay of collagenase steady-state mRNA
Total cellular RNA was isolated using the guanidinium
thiocyanate-CsCl method (38). Total RNA was quantitated by
optical density, and 3 /tg of RNA was subjected to Northern
analysis as previously described (39). Northern blots were
hybridized with an [a-32P]dCTP-labeled rabbit collagenase
cDNA (H9) (18) for 20 h at 56°C. Blots were washed twice for
10 min at room temperature, followed by two 30 min washes
at 560C (0.2 x SSC, 0.5% SDS). Collagenase-specific mRNA
was detected by autoradiography, and then the blots were stripped
and reprobed with the housekeeping gene GAPDH.
Autoradiographs were scanned using an E-C Apparatus Corp.
scanning densitometer with a Hewlett-Packard 3390A integrator
within the linear range of detection.
Transfection and CAT assay
Rabbit synovial fibroblasts were transfected using the calcium
phosphate co-precipitation method as we have previously
described (30). Briefly, 5 lsg of chimeric collagenase promoter-
CAT constructs were transfected with calcium phosphate for 6
h, followed by a 3 min shock with 10% glycerol. Cultures were
allowed to recover overnight, then washed and placed in DMEM
containing 0.2% lactalbumin hydrolysate. Since the transfected
cells were treated with IL-1 and PMA under serum-free condi-
tions, the proliferative effects of these agents were not seen. Some
cultures were stimulated with PMA (10-8 M) or IL-lI: (10
ng/ml) for 24 h. Cultures were then harvested, lysed by
freeze-thaw, and total cellular protein was determined by the
Bradford method (Bio-Rad). Three micrograms of protein were
incubated in a CAT assay mixture for 1 h at 37°C, and acetylated
[14C]chloramphenicol was separated from non-acetylated by
TLC. Acetylated and non-acetylated 14C was quantitated by
scintillation counting, and relative CAT activity was expressed
as percent incorporation. All assays were within the linear range
of the assay. Relative transfection efficiencies were determined
by the Hirt's assay (40).
RNAse protection assay
The induction of mRNA from transfected collagenase
promoter -CAT constructs was measured by RNAse protection
assay (41). Briefly, 20 Isg of total RNA from transfected cells
was hybridized to a radiolabeled CAT-specific antisense
riboprobe overnight at 60°C with shaking. This antisense probe
was transcribed from the pGemB-R plasmid linearized with
Hindm using T7 polymerase and the Riboprobe in vitro
transcription kit (Promega, Madison, WI). The hybridization
products were subjected to digestion with RNAse A (40 jig/ml)
and RNAse T1 (2 Ag/ml) and protected fragments were separated
on a sequencing gel. Samples containing no RNA or RNA from
untransfected cells were included as negative controls. Expression
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from the transfected human collagenase expression vector was
also detected in rabbit fibroblasts by RNAse protection. The probe
used in these studies was derived from a plasmid in which the
human cDNA was cloned into pSG5 in the opposite direction.
This plasmid was linearized at the XbaI site within the cDNA.
When this linearized plasmid was driven by the T7 RNA
polymerase promoter, a 402 nucleotide antisense riboprobe was
synthesized corresponding to the human 3' UTR. For detection
of the mutated human collagenase transcript (pSGSHuColjzu),
the mutated cDNA was cloned into pSG5 in the opposite dircion
and an antisense riboprobe was prepared as described above. For
detection of SV2CAT and SV2CATH9 transcripts, the CAT-
specific riboprobe described above was used.
Western blot analysis of coliagenase protein
One milliliter of serum-free conditioned media from stimulated
cultures was precipitated with 0.5 ml of cold 10% TCA for 30
min on ice. Protein was pelleted for 10 min at 15,000xg at 4°C,
washed with 0.1 M potassium acetate/95 % ethanol, followed by
an ethanol wash. Proteins were resuspended in sample buffer and
separated by reducing SDS-PAGE (39). Gels were transferred
to Immobilon-P membranes (Millipore Corp., Bedford, MA)
using a Trans-Blot Cell (Bio-Rad). Collagenase protein was
detected as previously described (27). Briefly, the membranes
were blocked for 1 h with 10% FCS, then probed with rabbit
collagenase-specific antiserum (27) at a dilution of 1:10,000 for
3 h. The membranes were then washed and specific antibody
binding was detected with the Vectastain ABC kit (Vector
Laboratories, Burlingame, CA).
Assay of DNA binding proteins
Nuclear protein extracts were prepared as previously described
(42). Two 150 mm confluent plates of RF were stimulated as
described, harvested and washed twice in Tris-buffered saline,
pH 7.9. Cells were then resuspended in 400 ml of cold buffer
A (10 mM HEPES, pH 7.9; 10 mM KCI; 0.1 mM EDTA; 0.1
mM EGTA; 1 mM DTT; 1 mM PMSF) using a P200 pipetteman
tip. After allowing the cells to swell on ice for 15 min, the cells
were lysed by the addition of NP40 (final concentration 0.6%).
Lysis was completed by vortexing vigorously for 10 s. The
homogenate was centrifuged for 30 s in a microfuge and the
nuclear pellet was resuspended in 50 jd of cold buffer C (20mM
HEPES, pH 7.9; 0.4 M NaCl; 1 mM EDTA; 1 mM EGTA;
1 mM PMSF; 1 mM DTT). This suspension was agitated at 4°C
for 15 min, and then pelleted in a microfuge for 5 min at 4°C.
The resulting supernatant was removed and stored in small
aliquots at -70°C. Protein concentrations were detemined using
the DC protein assay (Bio-Rad, Hercules, CA). For mobility shift
assays, 5 ,.tg of nuclear extract was incubated for 15 min on ice
in the presence of 2 ,ug poly(dI:dC), 1 ,ug BSA, 1 ,ug salmon
sperm DNA, 10% glycerol, 25 mM HEPES, pH 7.9, 0.5 mM
EDTA, 0.5 mM DTT, 0.1 M NaCl and 10,000 c.p.m. Of 32p-
labeled AP-1 or mutant AP-1 oligonucleotide.
AP-1 oligonucleoide: 5'-GAAAGCATGAGTCACACAGCCCTCAGCT-3'
3'-CTTTCGTACTCAGTGTGTCGGGAGTCGA-5'
Mutant AP-I oligonucleotide: 5'-GAAAGCAGGAGTCACACAGCCCTCAGCT-3'
3'-CTTTCGTCCTCAGTGTGTCGGGAGTCA-5'
Following a 15 min incubation at 370C, samples were loaded
onto a 4% polyacrylamide gel (1 xTBE) and electrophoresed at
150 V at 4°C. The gel was then dried and visualized by auto-
radiography.
RESULTS
II-1,8 increases secreted coflagenase protein and steady-state
levels of collagenase mRNA in rabbit synovial fibroblasts
We first confirmed that human IL-1l3 could induce collagenase
in rabbit fibroblasts. Confluent cultures of RF were placed in
serum-free media and either left untreated, or treated with 10
nM PMA or various concentrations of IL-113. After 48 h,
conditioned media were harvested and subjected to Western blot
analysis for rabbit collagenase (Figure l, panel A). IL-1I3
increased production of collagenase protein in a dose-dependent
manner, and the level of induction observed between 10 and 100
ng/ml IL-1to was similar to that seen with PMA. To determine
if this correlated with an increase in collagenase steady-state
A
PMA
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mm
-4.*
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FIgure 1. Interstitial collagenase gene expression in rabbit synovial fibroblasts.
(A) RF were cdtured to confluency inDMEM plus 10% FCS, washed with HBSS,
then cultured for 48 h in DMEM plus 0.2% lactalbumin hydrolysate (LH), LH
plus PMA (10 nM) or LH plus IL-1jI at thecontr indicatd. One mifliliter
of conditioned media was precipitated with TCA, subjected to reducing
SDS-PAGE, and ransferred to PVDF filters. Collagease prein was visualized
using a monospecific antibody previously described (27) (see Materials and
Methods). (B) Confluent cultures of RF were washed with HBSS and placed in
DMEM-LH. PMA (10 nM) or IL-1(3 (10 ng/ml) was added to selected culures.
At the time points indicated, total RNA was isolated and subjected to Northem
analysis. Collagenase mRNA was detected using the rabbit colagenase cDNA
H9 and visualized with autoradiography. Blots were then stripped and probed
with the housekeeping gene GAPDH as a loading control.
- 1.-
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mRNA, Northern blot analysis was performed on total RNA
isolated from RF at various time points after stimulation with
IL-1$ (Figure 1, panel B). Steady-state levels of collagenase
[ PMA mRNA in untreated cultures remained undetectable for 12 h, with
[3IL-1 a slight increase seen after 24 h under serum-free conditions.In contrast, cultures stimulated with 10 ng/ml IL-13 demonstrated
a rise in collagenase mRNA after 6 h, with peak induction at
12 h. Since unstimulated cultures showed no detectable message
after 12 h, the maximal fold induction by IL-1 could not be
determined. In other experiments, basal levels of collagenase
mRNA were detectable at 12 h, and densitometric analysis
showed 20-fold induction above control levels in IL-1j-treated
cells (data not shown). At 24 h, IL-1(-stimulated collagenase
mRNA began to deline and by 48 h, the signal was only 38%
of the maximal level.
cCRT 127 For comparison, in cells treated with PMA, collagenase mRNAlevels rose more slowly, but continued to increase over 48 h.
At 48 h, densitometric analysis showed - 20-fold induction above
control levels in PMA-treated cells. These data confirm that
increases in collagenase mRNA are paralleled by an increase in
collagenase protein (18) and demonstrate that recombinant human
IL-1j3 can induce collagenase gene expression to a level
comparable to that seen in PMA-stimulated cells. However, the
differential time course for these two stimuli suggests different
mechanisms of action.
* PMA
* IL-1 The rabbit coliagenase promoter is less responsive to IL-1,8
than PMA
The increase in steady-state levels of collagenase mRNA has been
attributed previously to transcriptional activation of the
collagenase promoter (26,29,30). To determine if sequences in
the collagenase promoter are responsive to IL-1$, RF were
transiently transfected with 5' deletion fragments of the
collagenase promoter linked to the CAT reporter gene (30). As
reported (30), we found that constructs containing 1176, 321,
182 or 127 bp of the collagenase 5' flanking region respond well
to PMA (Figure 2, panel A). In contrast, IL-1,B activated only
the 1176 bp constructs, and this was -3-fold above control,
No pcCAT pcCAT pcCAT
Plas mid 4 700 .1 8 OQ 1 17 6
516
298
+ CAT mRNA220
S: I
4
-,
Figure 2. Expression of transiently transfected collagenase promoter constructs
in RF. (A) RF were transfected in triplicate with pcCAT clones containing 1176,
321, 182, and 127 bp of the collagenase promoter using the calcium phosphate
co-precipitation method. The cells were allowed to recover for 18 h in serum-
containing media. Cultures were washed with HBSS, placed in LH and then left
untreated, or treated with PMA (10 nM) or IL-1,B (10 ng/ml). Twenty four hours
later, cytoplasmic protein was isolated and CAT activity was assayed. The percent
incorporation for unstimulated cultures ranged from 4.2% (pcCAT1 176) to 0.5%
(pcCAT127), and remained within the linear range of the assay for induced
cultures. CAT activity for PMA- and IL-1(3-stimulated cells is presented as fold
induction above control. (B) Constructs containing 4700, 3900, 2400 and 1800
bp of the collagenase promoter were assayed for their ability to drive CAT gene
expression in response to 10 nM PMA or 10 ng/ml IL-1,8. Induction is presented
as fold above unstimulated cultures. (C) Rabbit synovial fibroblasts were transfected
with constructs containing 4700, 1800 and 1200 bp of the collagenase promoter,
and then allowed to recover for 18 h in serum-containing media. The cultures
were then washed with HBSS and placed in LH, (C) or LH containing either
10 nM PMA (P) or 10 ng/ml IL-1j3 (IL). After 24 h, total RNA was isolated,
and CAT-specific mRNA was assayed by RNAse protection assay as described
in the Materials and Methods section. The molecular weight markers (MW) used
consisted of a kinase labeled 1 kb DNA ladder (BRL, Bethesda, MD). The 'No
Plasmid' lanes refer to RNA samples isolated from untransfected cultures. Samples
were assayed by Northern analysis to ensure equal loading (Data not shown).
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despite the fact that the endogenous gene was activated to a level
comparable to that seen with PMA (data not shown). Thus
proximal promoter sequences which can drive collagenase gene
transcription in response to PMA do not respond to IL-1j.
We next tested more distal regions which contained as much
as 4700 bp of the collagenase promoter (Figure 2, panel B). All
distal promoter constructs responded well to induction with PMA.
In contrast to studies with the 1176 bp promoter, transcriptional
induction by IL-lIO improved as larger segments of the promoter
were included. A clone containing 4700 bp of collagenase 5'
flanking sequence demonstrated - 5-fold induction above
unstimulated levels in response to IL-1,B. A similar level of
transcriptional activation was also observed in nuclear run-on
analysis of IL-13-treated cells (data not shown).
We used RNAse protection assays to confirm that the observed
levels of CAT protein represented increases in CAT mRNA.
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(Figure 2, panel C). As was seen in the CAT assays, PMA and
IL-1 induced CAT gene expression from the 4700 bp construct,
and this induction was considerably more pronounced in PMA-
treated cells. In contrast, cells transfected with the smaller
promoter constructs (1800 and 1176 bp) showed CAT transcript
only in PMA-treated cells. Interestingly, CAT activity, but not
CAT transcript, was detectable in cells transfected with the 1176
bp construct and stimulated with IL-1,8 (Figure 2, panels A and
C). This is probably due to the fact that CAT protein is very
stable and serves as a record of totaltr l activity from
transiently transfected plasmids. In contrast, expression of the
CAT transcript is a more transient event. It is therefore likely
that the small amount of transcript produced by the 1176 bp
construct declined below the level of detection of the RNAse
protection assay. This is supported by our finding that the
induction of collagenase mRNA by IL-1j3 is transient, and
declines after 12 h (Figure 1, panel B). Taken together, the CAT
assay and RNAse protection data demonstrate that compared to
stimulation with PMA, IL- I treatment results in only a moderate
level of transcriptional activation which depends on the presence
of additional upstream promoter sequences.
Expression of AP-1 binding activity and c-jun mRNA in
ILM-10-treated cells
The transient transfection experiments with the collagenase
promoter constructs indicated that PMA and IL-1,8 udlize
different promoter elements for transcriptional activation. While
the transactivation of collagenase by phorbol esters is mediated
through the activating protein (AP-1) binding site located in the
proximal promoter (29,30), the proximal constructs containing
an intact AP-1 site do not respond well to IL- 1j (Figure 2, panels
A and B). To examine if this is due to rpson, or a lack of
AP-1 binding activity, nuclear extracts from PMA- or IL-1,8-
treated cells were assayed by mobility shift assay (Figure 3, panel
A). There is no detectable AP-1 activity after 6 h of culture in
serum-free media, or in cells treated for 6 h with IL-1,8. Cells
treated with PMA show AP-1 binding activity after 6 h, and by
12 h this represents a 12-fold increase above control levels.
However, in contrast to PMA, cells cultured for 12 h in IL-1,B
show only minimal induction above control levels.
c -- jun
Control PMA Il -lRA
-dip4_ _ _
doiEb 4SM qM 00 40 *W
Figure 3. Activation of AP-1 binding activity and c-jun gene expression in RF
in response to PMA and IL-1,8. (A) Nuclear extracts were isolated from untrated,
PMA-treated or IL-lj3-treated RF at 6 and 24 h. Five micrograms of extract was
incubated with a 32P-labeled oligonucleotide corresponding to -83 to -57 of
the collagenase promoter, which contains the AP-1 site. The mutant AP-1 oligo
has a T-G transversion which has been shown to ablate DNA binding activity
(29). DNA-protein complexes were run on a 4% polyacrylamide gel and exposed
to X-ray film for 48 h. (B) RF were untreated or stimulated with 10 nm PMA
or 10 ng/ml IL-1,8 and total RNA was isolated at the time points indicated. Total
RNA was subjected to Northem analysis and probed with a radiolabeled c-jun
cDNA (ATCC). Equal loading of total RNA is demonstrated by ethidium bromide
stained 18S and 28S ribosomal RNA.
SV2(1CrA I
Figure 4. Expression of SV2CAT in rabbit synovial fib . Rabbit synovial
fibroblasts were transfected with SV2CAT and cultured isDMM plus 10% FCS
for 18 h. Cultures were then washed with HBSS and placed in LH. Triplicate
cultures were then treated with nothing (control), PMA (10 nM) or IL-1l3 (10
ng/ml). ITwenty four hours later, cytoplasmic protein was isolated and CAT activity
was assayed.
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A mutant AP-1 probe, containing a T- G transversion at
nucleotide -77 of the collagenase promoter, was also tested. This
mutation has been shown to ablate AP-1 binding at its recognition
site (29). PMA-treated extracts did not bind to the mutant AP- 1
probe, indicating that the binding activity observed with the wild-
type probe was specific (43). Thus we conclude that IL-1,B is
not a strong inducer of AP-l binding activity in RF.
The AP-l protein is composed of homodimers of members of
the Jun family of transcription factors, or heterodimers of Jun
and Fos proteins (44). Activation of AP-1 binding by phorbol
esters is mediated through post-translation (45,46) modification
of Fos and Jun, as well as transcriptional activation of the genes
for these transcription factors (47). To determine if the low level
of AP-1 activity observed in IL-1l,-treated cells was at the pre-
or post-translational level, we assayed c-jun mRNA in RF (Figure
3, panel B). In unstimulated cells, there is a detectable increase
in c-jun mRNA after 6 h of culture in serum-free media. Cells
treated with PMA demonstrate a maximal increase in c-jun
message at 2 h. The induction of c-jun by PMA is transient, and
decreases by 40% at 6 h. In contrast to PMA-treated cells, IL-1$-
treated cells show no such increase at 2 h. After 6 h of IL-1,B
treatment, c-jun mRNA is only 1.2-fold above that seen in control
cultures. This is below the level of induction (2.5-fold) observed
for the declining signal of PMA-treated cells. These data suggest
that the minimal proximal promoter response and AP-1 activity
observed in IL-1,-treated cells is due, at least in part, to poor
activation of the c-jun gene.
Post-transcriptional regulation of the coliagenase gene
The discrepancy between the large increase in steady-state levels
of collagenase mRNA and the modest transcriptional induction
following IL-1,B treatment suggest that post-transcriptional
mechanisms may be important in IL-1$-dependent collagenase
gene expression. Previous studies have shown that transcription
inhibitors such as actinomycin-D and DRB either are toxic to
li nTreat ed
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Figure 5. Expression of the transfected human collagenase gene pSG5HuCol in
rabbit synovial fibroblasts. (A) To construct the clone pSG5HuCol, 1700 kb of
the human collagenase cDNA was clone into the EcoRI site of pSG5 (37) in the
orientation shown. The 1700 bp fragment was also cloned in the opposite
orientation, with the 3' UTR proximal to the T7 RNA polymerase promoter of
pSG5. When linearized at the XbaI site the reverse orientation plasmid yields
a template for a human collagenase 3' UTR-specific riboprobe. This riboprobe
was used to detect human collagenase transcripts in pSG5HuCol-transfected rabbit
synovial fibroblasts. The riboprobe did not protect endogenous transcripts from
untransfected rabbit synovial fibroblasts (data not shown). (B) Rabbit synovial
fibroblasts were transfected with pSG5HuCol and then cultured in DMEM plus
10% FCS for 18 h. Serum was then washed out and the cells were placed in
LH or LH plus IL-1,B (10 ng/ml). At the time points indicated, total RNA was
isolated by the guanidinium-CsCl method. Twenty micrograms of total RNA
were analyzed by RNAse protection assay and transcripts from the transfected
human gene were visualized using the human 3' UTR-specific anti-sense riboprobe.
The molecular weight markers (MW) used consisted of a kinase labeled 1 kb
DNA ladder (BRL, Bethesda, MD), and the 'No RNA' lane corresponds to the
riboprobe hybridized in the absence of cellular RNA. (C) Expression of the
endogenous rabbit collagenase gene in pSG5HuCol-transfected rabbit synovial
fibroblasts. Three micrograms of total RNA from the RNA samples analyzed
in panel B were also subjected to Northern blot analysis. Expression of the
endogenous rabbit collagenase gene was visualized by probing with the rabbit
cDNA H9. Equal amounts of total RNA were used in the experiments depicted
in panels B and C as demonstrated by ethidium bromide stained 18S and 28S
ribosomal RNAs.
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rabbit fibroblasts or stabilize the collagenase message (22,
Vincenti, unpublished observations), thereby making these
reagents unsuitable for studies of mRNA decay in this system.
Instead, we placed the collagenase gene under the constitutive
tanscriptional control of the SV40 early promoter, and t ly
transfected the SV40-collagenase chimeric constructs into rabbit
fibroblasts. The SV40 promoter drives ranscription at high levels
in mammalian cells (48,49) and is not modulatable in primary
fibroblasts by external stimuli (48). This approach eliminates
transcriptional activation of collagenase by IL-1,, so that the
effects of IL-1B on mRNA stability can be determined.
We confirmed our previous finding (48) that the SV40
promoter drives transcription of the CAT gene at high levels in
primary rabbit fibroblasts, and that this level of transcription is
not modulatable by PMA (Figure 4). Furthermore, the SV40
early promoter is not modulatable in RF by IL-1,8 (Figure 4).
Thus transient transfection of collagenase constructs under the
transcriptional control of this promoter is an effective system for
examining post-transcriptional regulation of the collagenase gene.
First we created the pSG5HuCol construct by placing 1.7 kb
of the human collagenase gene under the constitutive transcrip-
tional expression of the SV40 promoter (Figure 5, panel A). The
human collagenase cDNA was used for these experiments because
sequence divergence in the 3' UTR of the human (5) and rabbit
genes (28,50) allows specific detection of a human transcript in
rabbit cells, but does not detect endogenous rabbit sequence.
pSG5HuCol (Figure 5, panel A) was transfected into RF which
were then allowed to recover in media containing 10% serum
for 18 h (51). At this point, serum was removed and half of the
cultures were treated with IL-1,B. Total RNA was harvested at
various time points after serum wash-out and the stability of
transfected gene transcripts was assayed by RNAse protection
assay (Figure 5, panel B). The figure shows that cells cultured
for 18 h in serum contain high levels of human collagenase
mRNA. After 4 h in serum-free conditions, the human transcript
has not decayed in untreated or IL-l(3-treated cells. In untreated
cells, this transcript decays to about one half of its original level
after 12 h. In contrast, cells placed in serum-free media conining
IL-1I3 contained pSG5HuCol transcript levels at 12 h comparable
to those at the 0 h time point. This IL-1I-dependent enhancement
of pSG5HuCol transcripts was concomitant with an IL-1(3-
dependent rise in steady-state collagenase mRNA from the
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Figure 6. Expression of the transfected wild-type and ATTTA mutant-containing human collagenase cDNA in RF. (A) Homology analysis of part of the coding
sequence and the 3' UTR sequence of the human and rabbit colLagenase genes using the University of Wisconsin GCG 'GAP' program. Each line a
point of nucleotide identity. The stop codons are in bold and the polyadenylation signals are underlined. The consensus ATTTA sequences described by Shaw and
Kamen (35) are in bold and underlined. (B) The wild-type and mutant pSG5HuCol cDNAs were transfected into RF and assayed as in Figure 5 using anti-sense
riboprobes of the wild-type and mutant 3' UTRs.
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endogenous rabbit gene (Figure 5, panel C). These results suggest
that IL-1,8 increases steady-state levels of collagenase mRNA by
increasing the stability of the transcript.
Next we tested the role of the ATTTA motif in collagenase
mRNA stability (35,36). The 3' UTRs of the human and rabbit
collagenase genes each contain three copies of the mRNA
instability motifAT'TA (Figure 6, panel A) and the conservation
of this motif suggests that it may play a role in gene regulation.
Thus the ATTTA elements of the human gene were mutated in
the context ofpSG5HuCol (see Figures 5A and 6A). The resulting
clone, pSG5HuCol,u, was transiently transfected into RF, and
some cultures were treated with IL-lIO. The stability of transcripts
from the mutated human gene was then assayed by RNAse
protection (Figure 6 panel B). In untreated cells, the wild-type
transcript decays between 5 and 10 h of culture in serum-free
media, while it is stable during this time period in IL-1I3-treated
cells. In contrast, transcripts from the construct with mutated
ATTTA elements are stable between 5 and 10 h in untreated cells.
In IL-1(3-treated cells, the mutant transcript appears to be even
further stabilized. A lower molecular weight band is present in
pSG5HuCol- and pSG5HuColliu-transfected cells which appears
to be a product of RNA decay. These data suggest that the
ATTTA elements, which have been shown to destabilize cytokine
and proto-oncogene transcripts (35,36), also destabilize human
collagenase mRNA (see Discussion).
We have shown that the ATTTA motifs in the human
collagenase 3' UTR contribute to instability of the mRNA.
-SV40 PolvA
0 Small T Intron
B SV2CAT
CAT
Assay
Hirt's
Assay
However, it is not clear if the destabilizing function of the
ATTTA motif is conserved in the rabbit gene. Furthermore, it
is not known if the collagenase 3' UTR is a destabilizing element
in and of itself, as has been described for the GM-CSF 3' UTR
(35), or requires additional upstream sequences. To answer these
questions, we have tested the ability of the rabbit collagenase
3' UTR to act as a destabilizing element for the constitutively
expressed construct SV2CAT. For these studies, we cloned the
rabbit 3' UTR downstream of CAT coding sequences in the
SV2CAT construct. The resulting construct, SV2CATH9
(Figure 7, panel A) was then transfected into RF, and CAT gene
expression was assayed (Figure 7, panels B and C). The presence
of the rabbit collagenase 3' UTR resulted in decreased CAT gene
expression, as determined both by CAT activity assay and RNAse
protection of CAT transcript. The decreased CAT gene
expression was not due to reduced transfection efficiency of
SV2CATH9, as determined by Hirt's assay (Figure 7, panel D).
Thus, the 3' UTR of the rabbit collagenase gene is capable of
acting as a destabilizing element, and this ability does not require
upstream coding sequences.
DISCUSSION
In the present study, we have examined the induction of
collagenase gene expression in synovial fibroblasts treated with
IL-1$3. IL-lI3 treatment induced collagenase mRNA levels
comparable to PMA, but the time course for this cytokine was
C
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Figure 7. Expression of SV2CAT and SV2CATH9 in RF. (A) The construct SV2CATH9 was cloned by replacing the SV40 polyadenylation sequence of SV2CAT
with the rabbit 3' UTR. The rabbit 3' UTR contains 108 nt of coding sequence, three ATTTA elements, and a polyadenylation site (see Figure 6A). (B) CAT
protein expression in cells transfected with SV2CAT and SV2CATH9 was assayed as previously described. Transfection efficiency was determined by Hirt's assay
(40). (C) CAT transcript levels were assayed by RNAse protection assay in SV2CAT- and SV2CATH9-transfected cells.
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more rapid than PMA. In addition, induction by IL-I did not
involve a large transcriptional component, and depended on the
presence of distal promoter sequences. Finally, transcripts from
a transfected human collagenase gene decayed more slowly in
IL-1,-treated cells. The decay rate observed in untreated cells
depends, at least in part, on the presence of ATTTA sequences
in the 3' UTR, since mutation of these sequences stabilized
mRNA. These results suggest that IL-13 increases collagenase
gene expression by mechanisms that are distinct from PMA and
that involve increased mRNA stability.
We found that regions of the collagenase promoter which are
known to be responsive to PMA (29,30) are not sufficient for
IL-l3-mediated transcriptional activation. The 1176 bp
collagenase promoter construct transfected into fibroblasts
demonstrated a transcriptional response to IL-1,8 of only 2.9-fold
above control values. The minor IL-1,8 response of the 1176 bp
construct contrasted with the 18-fold induction observed for the
same construct in PMA-treated cells. The positive IL-1,8-
responsive elements appear to reside farther 5' in the collagenase
promoter, with increasing responsiveness observed with
increasing promoter size. Given the gradient of responsiveness
observed with increasing promoter size, multiple elements
probably cooperate for IL-1 -mediated transcriptional induction,
as has already been demonstrated for phorbol ester activation of
collagenase (30,43).
Transcriptional activation of the collagenase gene by PMA is
mediated at least in part by the AP-1 site located 77 bp 5' of
the transcriptional start site (29,30). This does not seem to be
the case for IL-1j, since this cytokine is not a strong inducer
of c-jun gene expression or AP-1 binding activity. It has been
reported (31) that IL-1 stimulates collagenase gene expression
through the AP-1 site in human rheumatoid synovial cells.
However, unlike our cells, these rheumatoid synovial cells
displayed high basal levels of c-jun gene expression. Such high
expression of this proto-oncogene might circumvent the normal
transcriptional activation pathways stimulated by IL-1.
The moderate transcriptional response observed with IL-1,B was
inconsistent with the dramatic increase seen in the level at steady-
state. This implied that post-transcriptional mechanisms may be
important for IL-l,B-mediated collagenase gene expression.
Indeed, post-transcriptional regulation of collagenase gene
expression has been demonstrated by others (22,34). However,
assessing the role of collagenase mRNA stability can be
problematic. This is due in part to the fact that mRNA levels
in unstimulated cells are too low to obtain accurate measurements
of half-life through pulse-chase methodology. Furthermore,
treatment of cells with transcription inhibitors can have a profound
effect on cellular physiology, and thus confound interpretation
of the results (52). MaCachren et al. (26) induced collagenase
mRNA with IL-1, then assayed the half-life in transcriptionally
arrested cells, both in the presence and absence of IL-1. In
contrast to our findings, these authors did not observe increased
mRNA stability in the presence of IL-1. However, since
transcriptional inhibitors themselves can stabilize the collagenase
mRNA (22, Vincenti, unpublished observations), experiments
with these drugs may be difficult to interpret.
To circumvent these difficulties, we used a constitutive
promoter system that does not require induction with cytokine,
and that does not need transcription inhibitors (52). It is important
to note that the plasmid SV2CAT, which is driven by the same
promoter as pSG5HuCol, is not modulatable by IL-1,B, indicating
mechanism of IL-1-mediated enhanced expression. With this
system, we found increased stability of the transfected human
transcript in IL-10-treated cells, and thismicrease is conomitant
with an increase in steady-state mRNA from the endogenous
rabbit gene, thus correlating transcript sbiliion with increased
steady-state levels.
We also found that the 3' UTR of collagenase transcripts play
an important role in mediating mRNA stability. The 3' UTR of
the rabbit collagenase gene acts as a destabilizing sequence when
inserted 3' of the CAT reporter gene. Inlwestingly, this region
of the gene was not sufficient to mediate CAT mRNA stabilization
in response to IL-lIO (data not shown), implying that additional
upstream sequences also play a role. Indeed, regulation of c-fos
mRNA stability is dependent upon sequences within the 3' UTR
as well as elements within the coding region (53). Destabilizing
elements, such as those which exist in the coding region of the
c-jbs taripts, may be required for IL-1-mediatedlization
of collagenase mRNA.
The 3' UTRs of the rabbit and human genes contain three
copies of the ATTTA motif which has been shown to contribute
to the strict post-transcriptional control of proto-onogene and
cytokine transcripts (35,36). Our finding that mutation of these
elements stabilizes the collagenase transcript in untreated and
IL-l,B-treated cells implies a role for these elements in the
collagenase gene as well.
A labile destabilizer has been described which mediates rapid
turnover of the c-nyc transcript (54). This cytosolic factor binds
to A+U-rich elements in the 3' UTR of the c-nyc transcript and
mediates selective degradation of this mRNA (36). An mRNA
destabilizing factor, such as that described for c-nyc, may be
present in resting cells, and may interact with the ATTTA
destabilizing motif found in the 3' UTR of the collagenase gene.
Mutation of this motif would ablate binding of a destabilizing
factor, resulting in increased transcript stability relative to the
wild-type. Similarly, upon stimulation with IL-1(, this factor may
be inhibited or degraded. This could explain the incrased stability
observed for the wild-type human transcript in IRL- 3-treated cells.
Previous studies of the molecular events involved in collagenase
gene induction by cytokines such as IL-1 and TNF have
concentrated on transcriptional activation (31,55). However,
optimal activation of the native collagenase promoter with these
cytokines has not been clearly demonstrated. A recent study
indicates that EGF induction of collagenase and stromelysin
involves post-transcriptional events (22). This cytokine induced
coliagenase steady-state mRNA levels 10-fold above control, with
only a 2-fold increase in transcription rate. Studies such as this
emphasize the importance of examining post-transcriptional
mechanisms when studying cytokine induction of collagenase
gene expression.
IL-1,8 is a potent inducer of interstitial collagenase gene
expression in fibroblasts. In the present study, we have
demonstrated that the molecular mechanism of IL-1l,-mediated
collagenase gene expression has both a trscriptional and a post-
transcriptional component.
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